Adcock saw its profits grow by 4.2% during FY 2024 despite a challenging economic environment.

Private equity firms partnering with senior management professionals bitten by the entrepreneurial bug to buy pharmaceutical businesses in India were some of the emerging trends highlighted by experts at a recent CPhI congress in Mumbai. Scrip covers the key conference highlights on the "maturing" Indian M&A market, including how foreign firms are shedding their older portfolios to reallocate resources to newer products.

Japan's Meiji group has acquired the Indian contract development and manufacturing firm Medreich for $290m catapulting its plans to develop a competitive play in the generics business and expand in Asia and other emerging markets.

MedImmune and Bristol announce immuno-oncology combination trials with new partners on the same day, while AC Immune and Piramal Imaging will collaborate to develop an Alzheimer’s diagnostic to trace abnormal Tau protein in neuronal tissue.